WinstonWınston
Back
Nutex Health logo

Nutex Health

NUTX
79
Medical - Care Facilities · Healthcare
Exchange
NASDAQ
Winston Score
79
Winston is happy
A high-quality business with solid fundamentals.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Exceptional
Growth
Good
Cash Flow
Exceptional
Stability
Strong
Valuation
Strong

Winston Score History

The full picture

Nutex Health is a healthcare company that owns and operates a network of micro-hospitals and freestanding emergency rooms across the United States. These are small, hospital-level facilities that treat patients who need urgent or emergency care but want to avoid the long waits and crowded conditions of traditional large hospitals. The company also runs a hospital management and analytics division that helps other healthcare facilities operate more efficiently.

Nutex makes money primarily by billing patients and their insurance companies — including private insurers and government programs like Medicare and Medicaid — for emergency and inpatient care. The company operates mostly in suburban and growing communities across states like Texas, Nevada, and Colorado, where demand for convenient emergency care is rising. Its strong operating margin of over 31% reflects the relatively lean cost structure of micro-hospitals compared to full-size facilities. The key growth driver is continued expansion of its facility network, while the main risk is regulatory and reimbursement pressure from insurers and government payers who scrutinize emergency facility billing practices.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-13.6% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+406.2% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

50.6%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$205M cash & investments

Quarterly Free Cash Flow

↑ Burn rate improving

Company generates more cash than it spends — no dilution risk from fundraising

Revenue declining

Nutex Health's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
67.0%
Premium pricing power — 67.0% gross margin
Profit after running costs
Operating Margin
57.8%
Excellent — 57.8% operating margin
Return on the money invested
ROCE
44.2%
Exceptional — 44.2% return on capital

ROIC above 25%. Every dollar invested in the business earns more than 25 cents back per year.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+6.9%
Slow sales growth (+6.9% YoY)
Profit growth
EPS YoY
+177.3%
Earnings growing fast (+177.3% YoY)

Earnings growing 25%+ a year. The compounder zone.

How steady the profit is
EPS Consistency
5/8 quarters
Mixed — about half the quarters showed growth

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
197%
Turns 197% of profit into real cash
Spare cash per sale
FCF Margin
41.2%
Converts sales into free cash efficiently (41.2%)

Free cash flow margin above 20%. Out of every $100 in sales, more than $20 is real cash they keep.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.62
Moderate — manageable debt (0.62)
Covers its interest
Interest Cover
18.42x
Comfortably covers interest (18.4x)

Interest coverage above 8. Profits cover interest many times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
7.2x
no trend
Attractive valuation — P/E 7.2

P/E under 10. The price tag is small relative to last year's profit.

Cheaper or dearer next year
P/E vs Forward
+0.4
GROWING
Earnings roughly flat

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial